TrialScientific reports2021

Improves symptoms and urinary biomarkers in refractory interstitial cystitis/bladder pain syndrome patients randomized to extracorporeal shock wave therapy versus placebo.

Yuan-Chi Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.